UGC Approved Journal no 63975(19)

ISSN: 2349-5162 | ESTD Year : 2014
Call for Paper
Volume 11 | Issue 4 | April 2024

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 8 Issue 6
June-2021
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2106807


Registration ID:
311614

Page Number

f763-f767

Share This Article


Jetir RMS

Title

Sonographic appearance of tubal pregnancy in patients treated with methotrexate

Abstract

BACKGROUND: The aim of the present study was to evaluate the effect of methotrexate (MTX) treatment on the ultrasonographic appearance of extrauterine pregnancy (EUP) and, particularly, to test the hypothesis that the ultrasonographic appearance is not predictive of treatment success. METHODS: A prospective cohort study. The study group included 51 women with tubal EUP who received a single-dose protocol of MTX. EUP was diagnosed whenever an intrauterine gestational sac was not identified by transvaginal ultrasonography , accompanied by an abnormal rise or plateau in hCG concentration. Serial TVUS was performed weekly until hCG normalization or the size of the ectopic mass declined to 1 cm2. RESULTS: Ectopic tubal mass was identifified on TVUS in 42 (78%) women with a mean size of 4 +/- 0.5 cm2. Following the first week of MTX injection, the mean size of the ectopic mass significantly increased to 6+/- 0.8 cm2 (P 0.02). The initial size of the ectopic mass was not related to the success of the treatment nor to serum hCG levels. Ultrasonographic resolution of the ectopic mass was documented in 25 women following a mean of 42 +/- 2 days (range 6–60 days) CONCLUSIONS: The initial size of a tubal pregnancy is not related to the success of MTX treatment. MTX treatment in tubal pregnancy is followed by an initial increase in the size of the ectopic mass. Accordingly, such enlargement of the ectopic mass should not be considered as a higher risk for failure of treatment.

Key Words

extra-uterine pregnancy/methotrexate/transvaginal ultrasonograph

Cite This Article

"Sonographic appearance of tubal pregnancy in patients treated with methotrexate", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.8, Issue 6, page no.f763-f767, June-2021, Available :http://www.jetir.org/papers/JETIR2106807.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"Sonographic appearance of tubal pregnancy in patients treated with methotrexate", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.8, Issue 6, page no. ppf763-f767, June-2021, Available at : http://www.jetir.org/papers/JETIR2106807.pdf

Publication Details

Published Paper ID: JETIR2106807
Registration ID: 311614
Published In: Volume 8 | Issue 6 | Year June-2021
DOI (Digital Object Identifier):
Page No: f763-f767
Country: -, -, India .
Area: Engineering
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

000541

Print This Page

Current Call For Paper

Jetir RMS